Vr Adviser, LLC 13F Holdings · Q2 2026
Vr Adviser, LLC reported 33 securities worth $3.30B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: APGE (34.18%), ORKA (11.97%), ERAS (9.94%). Among its top 25 positions this quarter: 4 added, 5 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $1.13B | 34.18% | 8.5M | Hold |
| 2 | ORKA | ORUKA THERAPEUTICS INC | $394.8M | 11.97% | 4.1M | Hold |
| 3 | ERAS | ERASCA INC | $327.8M | 9.94% | 17.9M | Added |
| 4 | SYRE | SPYRE THERAPEUTICS INC | $265.0M | 8.04% | 3.0M | Trimmed |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | $115.0M | 3.49% | 1.2M | Hold |
| 6 | OCUL | OCULAR THERAPEUTIX INC | $101.6M | 3.08% | 10.3M | Hold |
| 7 | DMRA | DAMORA THERAPEUTICS INC | $93.7M | 2.84% | 3.6M | Hold |
| 8 | SVRA | SAVARA INC | $90.8M | 2.75% | 14.7M | Added |
| 9 | JBIO | JADE BIOSCIENCES INC | $71.6M | 2.17% | 3.2M | Hold |
| 10 | COGT | COGENT BIOSCIENCES INC | $63.6M | 1.93% | 1.6M | Trimmed |
| 11 | VRDN | VIRIDIAN THERAPEUTICS INC | $59.8M | 1.81% | 3.3M | Trimmed |
| 12 | VOR | VOR BIOPHARMA INC | $56.0M | 1.70% | 3.0M | Hold |
| 13 | DYN | DYNE THERAPEUTICS INC | $48.3M | 1.46% | 2.2M | Hold |
| 14 | MAZE | MAZE THERAPEUTICS INC | $47.8M | 1.45% | 1.6M | Hold |
| 15 | RLMD | RELMADA THERAPEUTICS INC | $47.4M | 1.44% | 6.8M | Added |
| 16 | ORIC | ORIC PHARMACEUTICALS INC | $46.8M | 1.42% | 4.3M | Hold |
| 17 | CBIO | CRESCENT BIOPHARMA INC. | $38.4M | 1.16% | 2.1M | Hold |
| 18 | ZURA | ZURA BIO LTD | $38.0M | 1.15% | 6.4M | Hold |
| 19 | ANL | ADLAI NORTYE LTD | $36.9M | 1.12% | 3.2M | Hold |
| 20 | ELVN | ENLIVEN THERAPEUTICS INC | $26.7M | 0.81% | 526,331 | Trimmed |
| 21 | HELP | CYBIN INC | $25.5M | 0.77% | 3.9M | Hold |
| 22 | CGEM | CULLINAN THERAPEUTICS INC | $25.1M | 0.76% | 1.4M | Hold |
| 23 | IPSC | CENTURY THERAPEUTICS INC | $21.3M | 0.65% | 8.7M | Hold |
| 24 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $19.8M | 0.60% | 2.0M | Added |
| 25 | CTMX | CYTOMX THERAPEUTICS INC | $18.7M | 0.57% | 5.0M | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR